RxDoctor Payments Data

Anita Whitton

Family · Walton, KYNPI 1093823999

Payments from drug & device makers

$1,954in general payments, 2019–2025

Across 48 payments — averaging $40.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Novartis$134
  • Johnson & Johnson$56
  • Atricure, Inc.$52
  • Merck$44
  • Boston Scientific$38
  • plus $69 from 4 others

What the payments were for

  • Travel & lodging$1,27565%
  • Food & beverage$67935%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,954 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$4,337
Medicare patients
37
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan313$362,992
EliquisApixaban139$139,909
JardianceEmpagliflozin127$126,530
FarxigaDapagliflozin Propanediol50$42,039
Repatha SureclickEvolocumab36$24,022
XareltoRivaroxaban21$23,928
VascepaIcosapent Ethyl17$15,872
Praluent PenAlirocumab13$10,345
Eplerenone72$5,554
Metoprolol Succinate325$4,961
Mycophenolate Mofetil11$4,793
Torsemide160$3,533
Isosorbide Mononitrate ErIsosorbide Mononitrate85$2,140
Atorvastatin Calcium249$1,598
Rosuvastatin Calcium126$1,539

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$134$362,992313 claims
Boehringer IngelheimJardiance$14$126,530127 claims
AstraZenecaFarxiga$12$42,03950 claims
Johnson & JohnsonXarelto$56$23,92821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,374 family providers in Kentucky.

Other family in Walton

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →